Alfa Wassermann has named Mark Flocco and Dino DiCamillo as vice president and president, respectively, to its proteomic technologies division, Alfa Wassermann Proteomic Technologies.
Registering provides access to this and other free content.
Already have an account?Login Now.
Startup companies are taking on personalized medicine, CNET reports.
Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.
The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.
In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.